Immusoft Awarded $8M in Funding from the California Institute for Regenerative Medicine
Immusoft of CA, a wholly owned subsidiary of Immusoft Corporation, a clinical-stage cell therapy company dedicated to improving the lives of patients with rare or genetic diseases, announced today that it has received an $8 million grant from the California Institute for Regenerative Medicine. This funding will support a Phase I study to assess the … Read more